Aeolus Pharmaceuticals Inc. Announces Consolidated Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2014
For the year, the company reported contract revenue of $9,631,000 compared to $3,928,000 a year ago. Loss from operations was $80,000 compared to $2,698,000 a year ago. Net loss was $80,000 or $0.00 per basic and diluted share compared to $3,208,000 or $0.03 per basic and diluted share a year ago. Net loss attributable to common stockholders was $80,000 compared to $3,208,000 a year ago. Net cash provided by operating activities was $323,000 compared to net cash used in operating activities of $2,970,000 a year ago.